Publications by authors named "Isabelle Stoeckert"

Claim this Profile
W
What Next for the Science of Patient Preference? Interoperability, Standardization, and Transferability.
Kevin Marsh, Juan Marcos Gonzalez Sepulveda, Conny Berlin, Bennett Levitan, Marco Boeri, Isabelle Stoeckert

Patient· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action.
Rosanne Janssens, Liese Barbier, Mireille Muller, Irina Cleemput, Isabelle Stoeckert

Front Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Tools-Regulatory Considerations for Application in Clinical Trials.
Lian Gelis, Isabelle Stoeckert, Hans-Peter Podhaisky

Ther Innov Regul Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.
Christine E Hallgreen, Hendrika A van den Ham, Shahrul Mt-Isa, Simon Ashworth, Richard Hermann, Isabelle Stoeckert

Pharmacoepidemiol Drug Saf· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Shahrul Mt-Isa, Christine E Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Isabelle Stoeckert

Pharmacoepidemiol Drug Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis